MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies

Cited by papers we hold 8

• Unveiling the mechanisms and challenges of cancer drug resistance · 2024
  No notice
• HNF4A and GATA6 Loss Reveals Therapeutically Actionable Subtypes in Pancreatic Cancer · 2020
  No notice
• Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment · 2020
  No notice
• Lactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches · 2019
  No notice
• The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma · 2018
  No notice
• The Influence of Metabolism on Drug Response in Cancer · 2018
  No notice
• Lipid Metabolism and Lipid Droplets in Pancreatic Cancer and Stellate Cells · 2017
  No notice
• Overcoming Hypoxia-Mediated Tumor Progression: Combinatorial Approaches Targeting pH Regulation, Angiogenesis and Immune Dysfunction · 2016
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.